MediaMedic

First-in-Human RoLEP with Robotic Assistance: A New Milestone in BPH Surgery

By Peng Longmei 2025.04.07

At #EAU25, Dr. Rodrigo Ledezma and colleagues presented the first-in-human results from the ASTRA study, evaluating robotic-assisted Holmium Laser Enucleation of the Prostate (RoLEP) using the Beacon Platform.This novel robotic…

Real-World Eligibility in mPCa Trials: Insights from the APPLICABILITY Study Presented at EAU25

By Peter W. PENG 2025.04.06

At EAU25, Dr. Francesco Pellegrino from IRCCS San Raffaele Scientific Institute presented a crucial analysis on the generalizability of randomized trials in newly diagnosed metastatic prostate cancer (mPCa). Using the…

APPEAL Trial: Landmark International RCT Shows Ciprofloxacin Lowers Post-SWL Infection Risk

By Mourabit Halima 2025.04.06

Presented by Dr. Kari Tikkinen and team at EAU25, the APPEAL trial is the largest randomized controlled study to date evaluating the role of antimicrobial prophylaxis during shock wave lithotripsy…

BOND-003: Intravesical Cretostimogene Shows Durable Responses in High-Risk BCG-Unresponsive NMIBC

By Mourabit Halima 2025.04.06

Presented by Dr. Trinity Bivalacqua at EAU25, the BOND-003 Phase 3 trial showcases updated data on intravesical cretostimogene grenadenorepvec, an innovative oncolytic immunotherapy for patients with high-risk BCG-unresponsive non–muscle invasive…

PROQURE-I: Promising Phase I Data on [¹⁷⁷Lu]Lu-PSMA-617 in Curative Treatment of N1 Prostate Cancer Presented by Dr. Lotte G. Zuur at EAU25

By Peng Longmei 2025.04.06

At #EAU25, Dr. Lotte Zuur from the The Netherlands Cancer Institute presented the first results of the PROQURE-I study, a phase I trial evaluating the addition of [¹⁷⁷Lu]Lu-PSMA-617 to standard…

“Shared decision-making isn’t just a concept—it’s a measurable determinant of patient satisfaction.”

By Peter W. PENG 2025.04.04

At hashtag#EAU25, André Deschamps presented the results of the Europa Uomo Patient REported Shared decision making Study (EU-PRESS), shedding light on the link between perceived shared decision-making (SDM) and decision…

Dr. Sarah Psutka MD MSc presents interim results from the SunRISe-4 trial at EAU25

By Mourabit Halima 2025.04.04

At the EAU25 Congress, Dr. Sarah Psutka MD MSc shared promising data from the SunRISe-4 trial evaluating neoadjuvant TAR-200 plus cetrelimab in patients with muscle-invasive bladder cancer (MIBC) who are…

EAU25 | Dr. Dr. med. Yannic Volz Presents the PRACTICE Study: Can Prehabilitation Improve Radical Cystectomy Outcomes?

By Mourabit Halima 2025.04.03

At #EAU25, Dr. Yannic Volz (Ludwig-Maximilians-Universität München) introduced early insights from the ongoing PRACTICE trial (NCT06806059), a randomized, single-blinded study assessing the impact of structured physical activity before radical cystectomy…

EAU25 | Sustainability in Uro-Oncology: Comparing the Carbon Footprint of RC vs CRT

By Peng Longmei 2025.04.03

At #EAU25, Dr. Vera R. and colleagues from Erasmus MC presented the first study to assess the environmental impact and staff requirements of radical cystectomy (RC) versus chemoradiation (CRT) for…

EAU25 | Dr. Seth Lerner Shares First-in-Human Results on Bel-sar (AU-011) in NMIBC

By Mourabit Halima 2025.04.03

At #EAU25, Dr. Seth Lerner (Baylor College of Medicine) presented early findings from a Phase 1 study (NCT05483868) evaluating Bel-sar (AU-011)—a novel virus-like drug conjugate (VDC) for non-muscle invasive bladder…

BOC 2026 | Prof. Xinan Sheng: RC48-C016 Redefines First-Line Treatment for Advanced Urothelial Carcinoma, While Sequential ADC Strategies Open New Horizons in Later-Line Therapy

Pujiang Prostate Cancer Conference | Prof. Xiaojie Bian: Translating the Latest ASCO Advances into Precision Prostate Cancer Care and Driving Innovation in China

Pujiang Prostate Cancer Conference | Prof. Guowen Lin: Three Key Assessment Dimensions for Selecting Candidates for Salvage Prostatectomy and New Surgical Strategies for Recurrence After Focal Ablation

Pujiang Prostate Cancer Conference | Prof. Yao Zhu: The Clinical Significance of the APCCC Consensus—Bridging Clinical Guidelines and Real-World Practice

Pujiang Prostate Cancer Conference | Prof. Bo Dai Shares Clinical Experience with the Hood Technique for Robot-Assisted Radical Prostatectomy

BOC Spotlight on Precision HER2 Therapy | Disitamab Vedotin Sets a New Benchmark for China’s Homegrown Innovation

Pujiang Prostate Cancer Conference | Prof. Xiaojian Qin Discusses the Clinical Value and Surgical Experience of Primary Tumor Resection in Metastatic Prostate Cancer

Pujiang Prostate Cancer Conference | Prof. Yong Yang: The Predictive Value of Deep PSA Response and Treatment Optimization in mHSPC

ASCO China Voice | Professors Claudio Vernieri & Man Li: PALMARES-2 Highlights the Potential of CDK4/6 Inhibitor Beyond Progression and Combined Local Therapy

Rethinking the Limits of Flexible Ureteroscopy — An Interview with Prof. John D. Denstedt

BOC 2026 | Prof. Xinan Sheng: RC48-C016 Redefines First-Line Treatment for Advanced Urothelial Carcinoma, While Sequential ADC Strategies Open New Horizons in Later-Line Therapy

Pujiang Prostate Cancer Conference | Prof. Xiaojie Bian: Translating the Latest ASCO Advances into Precision Prostate Cancer Care and Driving Innovation in China

First-in-Human RoLEP with Robotic Assistance: A New Milestone in BPH Surgery

Real-World Eligibility in mPCa Trials: Insights from the APPLICABILITY Study Presented at EAU25

APPEAL Trial: Landmark International RCT Shows Ciprofloxacin Lowers Post-SWL Infection Risk

BOND-003: Intravesical Cretostimogene Shows Durable Responses in High-Risk BCG-Unresponsive NMIBC

PROQURE-I: Promising Phase I Data on [¹⁷⁷Lu]Lu-PSMA-617 in Curative Treatment of N1 Prostate Cancer Presented by Dr. Lotte G. Zuur at EAU25

“Shared decision-making isn’t just a concept—it’s a measurable determinant of patient satisfaction.”

Dr. Sarah Psutka MD MSc presents interim results from the SunRISe-4 trial at EAU25

EAU25 | Dr. Dr. med. Yannic Volz Presents the PRACTICE Study: Can Prehabilitation Improve Radical Cystectomy Outcomes?

EAU25 | Sustainability in Uro-Oncology: Comparing the Carbon Footprint of RC vs CRT

EAU25 | Dr. Seth Lerner Shares First-in-Human Results on Bel-sar (AU-011) in NMIBC

BOC 2026 | Prof. Xinan Sheng: RC48-C016 Redefines First-Line Treatment for Advanced Urothelial Carcinoma, While Sequential ADC Strategies Open New Horizons in Later-Line Therapy

Pujiang Prostate Cancer Conference | Prof. Xiaojie Bian: Translating the Latest ASCO Advances into Precision Prostate Cancer Care and Driving Innovation in China

Pujiang Prostate Cancer Conference | Prof. Guowen Lin: Three Key Assessment Dimensions for Selecting Candidates for Salvage Prostatectomy and New Surgical Strategies for Recurrence After Focal Ablation

Pujiang Prostate Cancer Conference | Prof. Yao Zhu: The Clinical Significance of the APCCC Consensus—Bridging Clinical Guidelines and Real-World Practice

Welcome to Mediamedic 👋
It’s nice to meet you.

Welcome to Mediamedic 👋It’s nice to meet you.

Welcome to Mediamedic 👋
It’s nice to meet you.